Materia competitors

Zippia score 4.6

Competitor Summary. See how Materia compares to its main competitors:

BACHEM HOLDING has the most employees (1,140).

Work at Materia?

Share your experience

Materia vs competitors

Company	Founding date	Zippia score	Headquarters	# of Locations	Revenue	Employees
Materia	1998	4.6	Pasadena, CA	2	$27.1M	100
Arzeda	2008	3.6	Seattle, WA	1	$5.0M	36
Synthetic Genomics	-	4.0	Los Angeles, CA	2	$45.0M	750
TetraVitae Biosciences	2006	4.0	Chicago, IL	1	$4.1M	30
TDA Research	1987	3.4	Wheat Ridge, CO	1	$2.4M	50
Univation Technologies	1997	4.2	Houston, TX	1	$25.0M	200
ChromaDex	1999	3.6	Irvine, CA	4	$72.1M	115
Natural Advantage	1996	3.9	Oakdale, LA	1	$8.9M	72
AZ Electronic Materials	1957	4.1	Bridgewater, NJ	1	$730.3M	810
BACHEM HOLDING	1971	4.3	Torrance, CA	2	$3.0B	1,140
SPEX CertiPrep	1954	3.9	Metuchen, NJ	1	$13.1M	53
Persedo Spirits	2007	3.3	Alvin, TX	1	$180,000	5
FutureCeuticals	1999	4.2	Momence, IL	1	$31.0M	69
Vitro Biopharma	1986	3.0	Golden, CO	1	$84,704	2

Rate Materia's competitiveness in the market.

Materia salaries vs competitors

Compare Materia salaries vs competitors

Company	Average salary	Hourly salary	Salary score
Materia	$45,867	$22.05	-

Compare Materia job title salaries vs competitors

Company	Highest salary	Hourly salary
Materia	$70,985	$34.13
Synthetic Genomics	$87,788	$42.21
SPEX CertiPrep	$71,050	$34.16
AZ Electronic Materials	$70,913	$34.09
BACHEM HOLDING	$70,798	$34.04
Natural Advantage	$70,716	$34.00
TetraVitae Biosciences	$70,677	$33.98
FutureCeuticals	$70,639	$33.96
TDA Research	$70,577	$33.93
Arzeda	$70,536	$33.91
Persedo Spirits	$70,522	$33.90
Vitro Biopharma	$70,522	$33.90
Univation Technologies	$70,498	$33.89
ChromaDex	$65,204	$31.35

Do you work at Materia?

Does Materia effectively differentiate itself from competitors?

Materia jobs

Materia demographics vs competitors

Compare gender at Materia vs competitors

Job title	Male	Female
ChromaDex	50%	50%
BACHEM HOLDING	62%	38%
Materia	-	-

Male

Female

100%

75%

50%

25%

Materia

BACHEM HOLDING

ChromaDex

25%

50%

75%

100%

Compare race at Materia vs competitors

Company	White	Hispanic or Latino	Black or African American	Asian	Unknown	Diversity score
ChromaDex	62%	19%	5%	7%	8%	6.1
BACHEM HOLDING	40%	26%	6%	18%	10%	9.2

Materia and similar companies CEOs

CEOBio

Robert N. Fried

ChromaDex

Robert Fried is a Chief Executive Officer at CHROMADEX CORP., Chief Executive Officer at Spirit EMX LLC, and Board Member at CHROMADEX CORP.. He has worked as President/CEO at Savoy Pictures Entmt Inc; Co-Chairman at Ideation Acquisition Corp; and Chairman at FLUENT, INC.. Robert studied at Columbia University Graduate School of Arts & Science and Cornell University.

Dr Jack Zamora

Vitro Biopharma

Geoff Wild

AZ Electronic Materials

Girish Srinivas

TDA Research

Girish Srinivas is the Chief Executive Officer and Partner at TDA Research. Girish attended The University of Colorado Boulder.

Thomas Meier

BACHEM HOLDING

Alexandre Zanghellini

Arzeda

Alexandre Zanghellini is a co-founder of Arzeda and serves as its Chief Executive Officer. Along with Arzeda’s management team, he is responsible for day-to-day operations and also leads Arzeda’s product and technology development and IP strategy. Alex is one of the inventors of Arzeda’s synthetic biology platform for novel enzyme and metabolic pathway design and is a keen believer in the power of biotechnology to solve some of our biggest societal challenges. Before founding Arzeda, Alex held positions in research and development both in academia and industry. He holds a Ph.D. from the University of Washington and a M.Sc. Eng. from ENSTA/ParisTech in Paris, France.

Oliver Fetzer

Synthetic Genomics

Dr. Fetzer has served as CEO and Board Member of Synthetic Genomics since November 2014. Previously, Dr. Fetzer served as President and CEO of Cerulean Pharma Inc. for five years, a pharmaceutical company that develops nanoparticle drug conjugate oncology therapeutics. Under Dr. Fetzer’s leadership, Cerulean advanced from a pre-clinical platform company to become a publicly traded clinical development stage company with a pipeline of product candidates. Prior to Cerulean Pharma, Dr. Fetzer served for five years in a variety of positions of increasing responsibility at Cubist Pharmaceuticals, Inc., including Senior Vice President, Corporate Development and Chief Business Officer, and Senior Vice President, Corporate Development and Research & Development. Dr. Fetzer began his career at the Boston Consulting Group (BCG), a global leading management consulting firm, where he advanced over nine years from Consultant to Project Leader, Principal, and ultimately Partner and Managing Director.

Michael F. Roman

Univation Technologies